Quantitative flow cytometric determination of cytoplasmic bcl-2 oncoprotein in peripheral blood lymphocyte subsets

Japanese Journal of Clinical Immunology

Volumn 20, Issue 1, 1997, Pages 14-20

  Yoshida, Miyoko ^a   Ichikawa, Yukinobu ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Bcl 2 oncoprotein; Fas antigen (CD 95); Flow cytometry

Indexed keywords

PROTEIN BCL 2;

ADULT; ARTICLE; BLOOD; CHEMISTRY; CYTOPLASM; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE SUBPOPULATION;

ADULT; CYTOPLASM; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE SUBSETS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0031068707     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.20.14     Document Type: Article

References (16)

1. Tsujimoto, Y., Finger, L.R., Yunis, J., et al.: Cloning of the chromosome breakpoint of neoplastic B cell with the t (14; 18) chromosome translocation. Science, 226: 1097–1099, 1984.
2. C.E., Gauwerky, F.G., Haluska, Y., Tsujimoto, et al., Evolution of B-cell malignancy: Pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL 2 gene, Proc. Natl. Acad. Sci. USA, (1988), 85, 8548-8552
3. Hockenbery, D.M., Zutter, M., Hickey, W., et al.: BCL 2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA., 88: 6961–6965, 1991.
4. Broome, H.E., Dargan, CM., Krajewski, S., et al.: Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J. Immunol., 155: 2311–2317, 1995.
5. Ichikawa, Y., Arimori, K., Yoshida, M. et al.: Abnormal expression of apoptosis-related antigens, Fas and bcl-2, on circulating T-lymphocyte subsets in primary Sjögren’s syndrome. Clin. Exp. Rheumatol., 13: 307–313, 1995.
6. Aringer, M., Wintersberger, W., Steiner, C. W., et al.: High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum., 37: 1423–1430. 1994.
7. Ohsako, S., Hara, M., Harigai, M., et al.: Expression and function of Fas an tigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin. Immunol. Immunopathol., 73: 109–114, 1994.
8. Shima, Y., Nishimoto, N., Ogata, A., et al.: Myeloma cells express Fas antigen/Apo-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood., 85: 757–764, 1995.
9. Lynch, D.H., Ramsdell, F., and Alderson, M. R.: Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today., 16: 569–574, 1995.
10. Aiello, A., Delia, D., Borrello, M.G., et al.: Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells. Cytometry, 13: 502–509, 1992.
11. Reed, J.C., Miyashita, T., Cuddy, M., et al.: Regulation of p 26-Bcl-2 protein levels in human peripheral blood lymphocytes. Lab. Invest, 67: 443–449, 1992.
12. Nicoletti, I., Migliorati, G., Pagliacci, M.C., et al.: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol; Metho., 139: 271–279, 1991.
13. Pollice, A.A., McCoy, J.P. Jr, Shackney, S.E., et al.: Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteins. Cytometry., 13: 432–444, 1992.
14. Yoshino, T., Kondo, E., Cao, L., et al.: Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood, 83: 1856–1861, 1994.
15. Massaia, M., Borrione, P., Attisano, C., et al.: Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients. Blood, 85: 3679–3687, 1995.
16. Graninger, W.B., Seto, M., Boutain, B., et al.: Expression of Bcl-2 and Bcl-2 Ig fusion transcripts in normal and neoplastic cells. J. Clin. Invest, 80: 1512–1515, 1987.